1 Menstrual disorders—an overview
review
OA: closed
CC0
⤵ 4 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
This paper provides an overview of menstrual disorders, covering their various types, causes, and potential management strategies.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (42)
- Endogenous levels of prostaglandin F2α and its main metabolites in plasma and endometrium of normal and dysmenorrheic women via openalex
- Endometrial and Myometrial Prostaglandin Release during the Menstrual Cycle in Relation to Menstrual Blood Loss* via openalex
- Endometrial prostaglandins in women with abnormal menstrual bleeding via openalex
- Increased uterine prostaglandin E receptors in menorrhagic women via openalex
- Laser photovaporization of endometrium for the treatment of menorrhagia via openalex
- Leukotriene release by endometrium and myometrium throughout the menstrual cycle in dysmenorrhoea and menorrhagia via openalex
- Primary and myoma‐associated menorrhagia: role of prostaglandins and effects of ibuprofen via openalex
- Prostaglandins in menstrual fluid in menorrhagia and dysmenorrhoea via openalex
- PROSTAGLANDIN SYNTHESIS IN THE ENDOMETRIUM OF WOMEN WITH OVULAR DYSFUNCTIONAL UTERINE BLEEDING via openalex
- REDUCTION OF MENSTRUAL BLOOD-LOSS BY PROSTAGLANDIN-SYNTHETASE INHIBITORS via openalex
- W2012165536 via openalex
- W2026799641 via openalex
- W2037691565 via openalex
- W2046468597 via openalex
- W2056895439 via openalex
- W2080413833 via openalex
- W2081012144 via openalex
- W2083717098 via openalex
- W2312278566 via openalex
- W2312649798 via openalex
- W2317251461 via openalex
- W2401780399 via openalex
- W2409787523 via openalex
- W2990150794 via openalex
- W3022729060 via openalex
- W4237531377 via openalex
- W4241837004 via openalex
- W4247970659 via openalex
- W6699437356 via openalex
- W6712981995 via openalex
- W6770583308 via openalex
- W187533940 via openalex
- W6821836598 via openalex
- W607264982 via openalex
- W613365139 via openalex
- W647302311 via openalex
- W1964830004 via openalex
- W1978711334 via openalex
- W1986685840 via openalex
- W1987909248 via openalex
- W2000210781 via openalex
- W2007529000 via openalex
Cited by (4)
Source provenance
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0
· commercial use OK